AR014096A1 - 17 ALPHA, 8,9-DEHYDROESTRADIOL AND 17 BETA DELTA 8,9 DEHYDROESTRADIOL, THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, A COMPOSITION PHARMACEUTICAL COMPOSITION AND A PROCEDURE FOR PREPARATION. - Google Patents

17 ALPHA, 8,9-DEHYDROESTRADIOL AND 17 BETA DELTA 8,9 DEHYDROESTRADIOL, THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, A COMPOSITION PHARMACEUTICAL COMPOSITION AND A PROCEDURE FOR PREPARATION.

Info

Publication number
AR014096A1
AR014096A1 ARP970104601A ARP970104601A AR014096A1 AR 014096 A1 AR014096 A1 AR 014096A1 AR P970104601 A ARP970104601 A AR P970104601A AR P970104601 A ARP970104601 A AR P970104601A AR 014096 A1 AR014096 A1 AR 014096A1
Authority
AR
Argentina
Prior art keywords
dehydroestradiol
procedure
manufacture
preparation
alpha
Prior art date
Application number
ARP970104601A
Other languages
Spanish (es)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR014096A1 publication Critical patent/AR014096A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

17alfa, delta 8,9-deshidroestradiol o sal farmacéuticamente aceptable de su éster de 3-sulfato, y 17beta,delta8,9-deshidroestradiol o una salfarmacéuticamente aceptable de su éster de 3-sulfato; el uso de los mismos para la manufactura de unmedicame nto, una composicion farmacéutica que loscomprende y un procedimiento para su preparacion.17alpha, delta 8,9-dehydrostradiol or pharmaceutically acceptable salt of its 3-sulfate ester, and 17beta, delta8,9-dehydrostradiol or a pharmaceutically acceptable salt of its 3-sulfate ester; the use of them for the manufacture of a medicine, a pharmaceutical composition that includes them and a procedure for their preparation.

ARP970104601A 1996-10-11 1997-10-06 17 ALPHA, 8,9-DEHYDROESTRADIOL AND 17 BETA DELTA 8,9 DEHYDROESTRADIOL, THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, A COMPOSITION PHARMACEUTICAL COMPOSITION AND A PROCEDURE FOR PREPARATION. AR014096A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2793696P 1996-10-11 1996-10-11

Publications (1)

Publication Number Publication Date
AR014096A1 true AR014096A1 (en) 2001-02-07

Family

ID=21840614

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970104601A AR014096A1 (en) 1996-10-11 1997-10-06 17 ALPHA, 8,9-DEHYDROESTRADIOL AND 17 BETA DELTA 8,9 DEHYDROESTRADIOL, THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, A COMPOSITION PHARMACEUTICAL COMPOSITION AND A PROCEDURE FOR PREPARATION.

Country Status (13)

Country Link
EP (1) EP0934334A1 (en)
JP (1) JP2001502328A (en)
KR (1) KR20000049055A (en)
CN (1) CN1239967A (en)
AR (1) AR014096A1 (en)
AU (1) AU743530B2 (en)
BR (1) BR9712628A (en)
CA (1) CA2268330A1 (en)
HU (1) HUP9903369A3 (en)
IL (1) IL129029A0 (en)
NZ (1) NZ335183A (en)
WO (1) WO1998016544A1 (en)
ZA (1) ZA979069B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020173499A1 (en) * 2001-03-16 2002-11-21 Wyeth Estrogen replacement therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES341947A1 (en) * 1966-06-21 1968-08-01 American Home Prod A procedure for preparing steroid compounds. (Machine-translation by Google Translate, not legally binding)
SU286675A1 (en) * 1969-01-10 1973-08-10 Институт химии природных соединений СССР WAY OF OBTAINING dl-ESTRADIOLAYSS-UNION fi ^ iffiTau - ::: X:.: F-lAfi LIBRARY
FR2136891A1 (en) * 1971-05-07 1972-12-29 Inst Khim Prirodny Racemic estra-3,17 beta-diol prepn - steroid hormones
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
DE4338314C1 (en) * 1993-11-10 1995-03-30 Jenapharm Gmbh Pharmaceutical preparations for the prophylaxis and therapy of radical-mediated cell damage

Also Published As

Publication number Publication date
WO1998016544A1 (en) 1998-04-23
HUP9903369A3 (en) 2002-02-28
NZ335183A (en) 2000-09-29
KR20000049055A (en) 2000-07-25
CA2268330A1 (en) 1998-04-23
AU5145998A (en) 1998-05-11
JP2001502328A (en) 2001-02-20
EP0934334A1 (en) 1999-08-11
HUP9903369A2 (en) 2001-06-28
BR9712628A (en) 1999-10-26
CN1239967A (en) 1999-12-29
ZA979069B (en) 1999-04-09
AU743530B2 (en) 2002-01-31
IL129029A0 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
AR004700A1 (en) 1ALFA, 26 DIHIDROXI-D-HOMO-VITAMIN D3, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, A PROCEDURE FOR ITS PREPARATION AND USE OF THEM IN THE ELABORATION OF A MEDICINAL PRODUCT
MX9204268A (en) A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME.
DE69331409D1 (en) ORAL 1ALPHA HYDROXYPREVITAMIN D
ITMI942484A0 (en) PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED OSMOTIC RELEASE AND BY DIFFUSION OF THE DRUG AND PROCEDURE FOR THEIR PREPARATION
AR008878A1 (en) VITRONECTIN RECEPTOR ANTAGONISTS, A METHOD FOR THEIR PREPARATION, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT.
CL2004001191A1 (en) COMPOUNDS DERIVED FROM STEROIDS 17 ALPHA-FLUORO RENTED, WITH ANTIGESTAGENA ACTIVITY; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMBINATION; AND USE OF THE COMPOUND IN THE PREPARATION OF AN ANTIESTROGENIC MEDICINAL PRODUCT, FOR THE TREATMENT OF DISMENORREA
ES2091877T3 (en) USE OF ANGIOTENSIN II ANTAGONISTS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HYPERURICEMIA.
IT8820145A0 (en) CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR THEIR PREPARATION.
GR1000465B (en) Process for manufacturing pharmaceutical compositions comprising acetyl d-carnitine for the therapeutic treatment of glaucoma
MX9204767A (en) NEW ISOSTERIC PEPTIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
ES2157958T3 (en) USE OF VENLAFAXINE OR AN ARYLOXYPROPANAMINE COMPOUND FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF URINARY INCONTINENCE.
ES2080307T3 (en) PHARMACEUTICAL COMPOSITIONS.
MX9200374A (en) NEW STEROID ESTERS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATION CONTAINING THEM.
ES2174629T3 (en) 14,15-CYCLOPROPAN-STEROIDS OF THE 19-NOR-ANDROSTAN SERIES, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THESE COMPOUNDS.
BR1100860A (en) Compound, anti-inflammatory drug, pharmaceutical composition, epimer r and epimer s of the compound
ES2031822T3 (en) A PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION WITH INHIBITING PROPERTIES OF RENINE.
ES2037385T3 (en) A MANUFACTURING PROCEDURE OF A PHARMACEUTICAL PREPARATION FOR LOCAL ADMINISTRATION.
UY26372A1 (en) "IMIDAZO-3-IL-AMINAS BICÍCLICAS PROCEDURE FOR ITS PREPARATION AND DRUGS THAT CONTAIN THEM"
HK1000283A1 (en) New derivatives of non-steroidal anti-inflammatory anaggesic and/or antipyretic substances their use and pharmaceutical formulations containg them
GT199700037A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS
PT98371A (en) Process for the preparation of ARABINOFURANOSIL-GUANIN 6-ALCOXI DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BR9915215A (en) Pharmaceutical composition for modified insulin sensitizer release
ECSP941120A (en) DERIVATIVES OF 1,5 BENZODIAZEPINA
ES2062137T3 (en) USE OF 5'-DEOXI-5'-METHYL-THIOADENOSINE, S-ADENOSYLMETIONINE AND ITS SALTS FOR THE PREPARATION OF REDUCING PHARMACEUTICAL COMPOSITIONS OF SEBORRHEA.
AR011437A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MIGRANES AND THE USE OF THE SAME IN THE PREPARATION OF A MEDICINAL PRODUCT.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal